OGIVRI

NDC 83257-004 · Biocon Biologics Inc.

Generic nametrastuzumab-dkst

Dosage formKIT

Marketing categoryBLA

Packages

83257-004-12 — 1 KIT in 1 CARTON (83257-004-12) * 20 mL in 1 VIAL, MULTI-DOSE (83257-003-11) * 20 mL in 1 VIAL (83257-002-11)

Q5114 — Injection, trastuzumab-dkst, biosimilar, (ogivri), 10 mg Medicare Part B payment limit (ASP + 6%): $31.95

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.